Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 6.96%
March 31, 2026 9.54%
December 31, 2025 6.88%
September 30, 2025 9.20%
June 30, 2025 11.60%
March 31, 2025 11.85%
December 31, 2024 9.28%
September 30, 2024 12.70%
June 30, 2024 14.02%
March 31, 2024 14.80%
December 31, 2023 10.16%
September 30, 2023 11.49%
June 30, 2023 8.11%
March 31, 2023 6.85%
December 31, 2022 2.95%
September 30, 2022 5.07%
June 30, 2022 3.57%
March 31, 2022 4.76%
December 31, 2021 7.09%
September 30, 2021 4.60%
June 30, 2021 8.12%
March 31, 2021 12.07%
December 31, 2020 9.01%
September 30, 2020 8.76%
June 30, 2020 6.73%
Date Value
March 31, 2020 12.43%
December 31, 2019 13.19%
September 30, 2019 7.92%
June 30, 2019 8.53%
March 31, 2019 10.13%
December 31, 2018 3.34%
September 30, 2018 9.04%
June 30, 2018 12.15%
March 31, 2018 17.23%
December 31, 2017 14.51%
September 30, 2017 12.04%
June 30, 2017 14.58%
March 31, 2017 19.86%
December 31, 2016 20.14%
September 30, 2016 15.77%
June 30, 2016 18.60%
March 31, 2016 16.50%
December 31, 2015 11.34%
September 30, 2015 15.73%
June 30, 2015 13.49%
March 31, 2015 19.04%
December 31, 2014 12.18%
September 30, 2014 13.65%
June 30, 2014 11.44%
March 31, 2014 13.91%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Iren Spa 3.34%
Acea SpA 59.97%
Hera SpA 9.33%
Ameren Corp. 28.92%
Avista Corp. 19.61%